Skip to main content

Thailand To Give Away 1 Million Cannabis Plants

The government will distribute 1 million free (low THC) cannabis plants to households across the country to mark a new rule allowing home grow

In a post that went instantly viral, Thailand’s Health Minister Anutin Charnvirakul just announced, via Facebook, that he was going to give away 1 million cannabis plants this summer. His goal? To encourage the plant to be grown in every household. About a third of the population works in agricultural jobs.

The giveaway will occur in June, after the new Thai rule allowing home grow comes into effect.

However, this is not a huge free-for-all. Citizens will be allowed to grow cannabis at home for medical purposes only, and even then, not until after notifying local authorities. However, cultivators will not be allowed to enter into commercial dealings with the plants without being specifically licensed to do so. They will also not be able to consume anything they grow at home with a THC level higher than 0.2%

How the government will be able to control such regulations domestically is also unclear.

The move comes as Thailand positions itself, globally, as a source of legal cannabis. It remains the only country in Southeast Asia to do so. Indeed, since 2018, the country has gradually loosened restrictions around CBD and hemp. As of this February, the country removed both cannabis and hemp from the national narcotics list. Cannabis is still technically illegal for recreational use although it essentially has just been decriminalized.

The plants given away by the government will also have less than 0.2% THC in them.

The Great Asian Hemp Revolution

China takes the prize for largest hemp producer in the world – although it is still illegal, with harsh penalties including jail time, to even possess hemp seeds. Thailand is clearly challenging this kind of policy in the region – although it may take some time for their Chinese neighbour to get inspired to come along for the ride.

Regardless, the steady progress towards legalization in Thailand is bound to make an impact – and not just domestically. The entire world is now watching the progress of reform in different countries, and there are few places where the debate is not progressing.

Thailand, however, because of its history with the plant, let alone the recent move to normalize its production, is likely to lead the way in this part of the world.

And in the meantime? Its citizens are going to be very familiar with how to grow the cannabis plant – no matter the percentage of THC found in it.

Here’s hoping other governments – starting in Europe – start thinking this way.

London Mayor Appoints Drug Commissioner To Explore Cannabis Legalization

Sadiq Khan appoints a former member of Tony Blair’s cabinet and current Labour shadow cabinet member to examine decriminalization

Sadiq Khan has been on at least a cannabis decriminalization kick for the past couple of years. He announced last year in April that he wanted to set up a commission to examine the impact of at least cannabis decriminalization. In January, he announced that he wanted to set up a decriminalization scheme in three London boroughs. This month, after visiting a cannabis plant in Los Angeles, he is moving forward with setting up his commission.

While City Hall in London does not have the power to change criminal law on a federal basis in the UK, it can certainly influence the debate.

Khan is particularly interested in two issues – producing income in the form of taxes for the state – and reducing cannabis-related arrests. Arrests for cannabis dropped by 56% after California legalized the cultivation, production, and sale of the plant.

Could The UK Follow Switzerland and Germany?

Khan’s commission will take another year to study the issue – in part by conducting a global survey on the health impacts of decriminalizing the plant.

In the meantime, however, both Germany and Switzerland will be moving towards a full-blown recreational market. In Switzerland, it is clear that the first step will be a highly limited, canton-by-canton trial that must first gain the approval of the federal government. In Germany, the indications are that the government will launch a fully functional market immediately.

By next year, when Khan’s commission reports back, there will, in fact, be (at least) four recreational markets in Europe (counting Malta) and potentially five if Luxembourg also takes the opportunity of the changing environment to release their plans. Holland’s national plan will kick in as of next year.

This is powerful evidence indeed – beyond of course the history of both Canada and the legalizing U.S. states.

The UK’s CBD Market May Also Provide a Model

The UK has actually moved ahead of many European states (including Germany) by allowing several thousand pre-approved CBD products onto the market. This government-sanctioned commercialization of the CBD industry could also lead the UK to move forward with full legalization, particularly if other countries in Europe are also moving forward on legalizing recreational use.

However, no matter what happens, there will still be a period of consideration – no matter what Khan and his commission come back with. And in the meantime, the UK will watch several markets in Europe begin to establish themselves, and potentially the US as well.

One thing is for sure. The British are not leading this one.

UK-Appointed Governor Prevents Cannabis Reform In Bermuda

In a move that was widely expected to happen the Governor of Bermuda, who is appointed by the United Kingdom, effectively vetoed a cannabis reform measure passed by Bermuda lawmakers.

While the decision to ‘reserve assent’ by the Governor was expected, it’s no less defeating for cannabis advocates in Bermuda and elsewhere around the world.

When public officials do not want to respect the will of the people and proceed to stand in the way of cannabis reform they seem to be increasingly pointing to international treaties as ‘justification’ to not allow reform to proceed, which is exactly what happened in Bermuda. Per Bernews:

“In terms of cannabis reform, the key international obligations are set out in United Nations Conventions [the 1961 Single Convention on Narcotic Drugs, and the 1971 Convention on Psychotropic Substances]. The Conventions permit legalisation of cannabis and cannabis products for medicinal and scientific purposes, and for certain industrial purposes, as long as appropriate regulatory oversight is put in place.

“The legalisation of cannabis for other purposes is not permitted under the Conventions. It is possible to decriminalise the possession of limited amounts of cannabis for personal use, but that is not the same as making cannabis legal, for example, for sale in shops and cafes.

“The Bill presented to me legalises cannabis for other purposes. So, it appears to me that the Bill is inconsistent with what I understand to be obligations that the UK and Bermuda have under the Conventions and assenting to the Bill would lead to a breach of those obligations.

“I therefore have no choice but to reserve Assent of the Bill under Section 35 [2] of Constitution and to notify the Secretary of State for Foreign, Commonwealth and Development Affairs.

It is worth noting that Canada signed on to the 1961 Single Convention on Narcotic Drugs that the Governor references. Canada also was represented at the 1971 convention that the Governor mentioned. Canada also allows the legal sales of cannabis ‘in shops’, all of which the Governor of Bermuda seems to not know about apparently (I am being sarcastic, of course).

The move by the Governor was pure reefer madness. Uruguay sells cannabis in pharmacies and at clubs, Canada sells cannabis in just about every way imaginable, and Malta will soon permit sales via private clubs as well.

If lawmakers in Bermuda want to launch a robust, legal cannabis industry then they should be allowed to do so. For the United Kingdom to stand in the way is ridiculous and a prime example of the lingering, negative effects of colonization.

Brazilian Researchers Determine That CBD Is Safe For Dogs

An area of the emerging cannabis industry that is often overlooked is cannabis products for pets. Worldwide, it is estimated that over half of the households around the globe own a pet and many of those households own more than one pet.

The most popular pet type around the world is dogs, with as many as 33% of households around the planet estimated to own at least one dog. With that in mind, any product that can effectively and safely help dogs live better lives is obviously something that there would be a tremendous demand for.

Medical cannabis products for pets is still a very young sector within the emerging cannabis industry, and quite a bit of research is needed to help ensure product safety.

However, at the macro level, cannabis appears to be safe for pets, especially cannabidiol, as long as it’s administered in the right dosage level. Below is more information about it via an abstract of a recent study conducted in Brazil:

The review was systematically performed in Medline (via Pubmed®) and Latin American and Caribbean Health Sciences Literature (LILACS) databases, with period restriction (between 1990 and 2021). The qualified articles (n=19), which met the previously established inclusion criteria, were critically evaluated.

Based on the literature review, it is possible to infer safety in the administration of cannabis-based products for the treatment of dogs, especially products rich in cannabidiol (CBD), free or with low concentrations of tetrahydrocannabinol, under the conditions evaluated. In addition, CBD products potentially promote improved quality of life and reduce pain perception in animals affected by canine osteoarthritis.

Finally, owing to the lack of large-scale and robust clinical research studies, the performance of clinical trials, considering the individual characteristics of each cannabis-based product (composition, concentration, nature of adjuvants, dosage form, route of administration), is strongly encouraged.

Now, before you run out and grab the nearest cannabis product that you can find and try to give it to your dog, keep the results of this study in context.

Dogs are far more sensitive to medications than humans, and not only is it important to get the right medical cannabis product designed specifically for a dog of a specific size, it is also important to use the right dosage level and use the right consumption method.

Check with a veterinarian prior to administering medical cannabis products to your dog or any other pet that you may have.

Medical Cannabis Associated With Sustained Improvements In Anxiety And Depression

Anxiety and depression are two of the most common mental health conditions that patients suffer from globally. As many as 275 million people suffer from anxiety worldwide, and roughly the same number of people suffer from depression around the world.

For many patients, anxiety and depression go hand in hand, and suffering from the conditions can be debilitating and negatively impact nearly every aspect of daily life.

Fortunately, the cannabis plant may be able to help treat both conditions, as described in a recent news release from NORML:

Calgary, Canada: Patients with symptoms of anxiety and/or depression report sustained improvements following the use of cannabis, according to survey data published in the journal Psychiatry Research.

Canadian investigators surveyed over 7,000 patients authorized to access medical cannabis products. The average age of subjects in the study was 50 years old. All of the study’s subjects belonged to a licensed Canadian medical cannabis clinic.

Authors reported “statistically significant improvements” between subjects’ baseline and follow up scores on validated measurements of anxiety and depression. Symptom improvements were sustained for at least one year.

“To our knowledge, this study is the largest completed to date examining the impact of medical cannabis use on anxiety and depression outcomes utilizing longitudinal data and validated questionnaires,” they concluded. “It provides evidence on the effectiveness of medical cannabis as a treatment for anxiety and depression that otherwise is not currently available, demonstrating that patients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements. This study offers reasonable justification for the completion of large clinical trials to further the understanding of medical cannabis as a treatment for anxiety and depression.”

Full text of the study, “Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study,” appears in Psychiatric Research.

Australia Has Issues A Quarter Million Cannabis Prescriptions Since 2016

Medical cannabis is increasingly prescribed for a multitude of conditions. Where does this indicate that the market ‘down under’ is headed?

According to researchers from the University of Sydney at the Lambert Initiative for Cannabinoid Therapeutics, anxiety, chronic pain and sleep disorders are the top three reasons that Australians seek a cannabis prescription. This is despite the limited number of trials supporting its use for either anxiety or sleep disorders.

Prescriptions have also increased dramatically over the last two years – although researchers were unable to determine if the rise in such requests was due to the Pandemic. Another unexplained trend revealed by the data set that has been gathered since the beginning of medical reform showed that Queensland prescribers represented over half of the prescriptions written nationally.

How Does This Compare with Germany?

Australia is perhaps the closest “Western” country to Germany in terms of timing and approach to initializing the legal cannabis market. Both countries approved medical use on a federal level about the same time (within a year of each other). And while Germany’s total number of prescriptions outnumbers the Australian total so far, they are certainly comparable.

The difference between the two countries, however, is that Germany is now moving solidly towards a recreational market. Australia seems mired in indecision.

When Will It Get Dank Down Under?

In Europe, there is now a pressing regional political issue to deal with. Namely, there is no way that Germany can sit the recreational reform question out with countries all around it (and in two cases bordering it) now proceeding with federally regulated recreational cannabis markets. Australia is a bit isolated in this regard, although it is, as a country, clearly following the global trend.

Australian producers are also trying to export to Germany (as well as eastern Europe).

The latest poll numbers show that Australians are currently split, 50-50 on whether the country should proceed with a recreational market. That has moved fairly dramatically in the last several years.

For this very reason, it is also highly likely that, at a bare minimum, the initiation of a recreational market in Germany might tip the scales. Everyone right now is looking for a new industry or line of revenue post Covid.

And then of course there is the ability to export to a fully recreational market or two in Europe.

Given all the possibilities now at stake, it is very likely that Australia will be one of the next major western economies to make the switch. Even if so far unannounced.

Swiss City Seeks 1,000 Volunteers For Recreational Cannabis Trial

The city, set to be the second after Basel, is gearing up for its pilot trial now on track for this autumn

Calling cannabis users in Lausanne! The government wants you for its first recreational cannabis trial.

A first in French-speaking Switzerland, the southern city will sell cannabis via a non-profit association located in the city centre. Called Cann-L, the project is currently being finalized and will require approval by the cantonal ethics commission.

The signup process is also not complete, but users can pre-register via an online signup form that asks the prerequisite questions. Eligibility includes being over the age of 18, that you live in Lausanne, and whether (and how often) you consume cannabis or cannabis products containing more than 1% THC. The organizers also want to know if you are breastfeeding.

Final selection will happen this fall, as the city launches the trial.

The Swiss Move Ahead – With Germany Close Behind

The Swiss will have five city trials underway before the end of the year. Other cities also moving towards launch this year include Basel, which just announced its own plans, as well as Zurich, Bern, and Geneva.

The impact of the national trial will be interesting to watch as it will be taking place in parallel to the launch of Germany’s new market – now expected to be authorized by the end of 2022 with implementation presumably within the next 18-24 months.

Given the fact that sources are confirming that the German government will set up a for-profit industry from the beginning, and even authorize special dispensaries for the same, the comparison between the two markets will be interesting to watch.

It is unlikely, however, that the German government will just pass legislation allowing limited trials. Statements coming out of Berlin over the last several weeks suggest that the Germans will go whole hog.

How this will impact the Swiss trials is another question – particularly as the participant numbers for Basel and Lausanne are low (only 1,400 participants between them).

Beyond this, of course, with an open border, it is not inconceivable that German products may start to end up in Switzerland. Legally or illegally.

As a result, it may be that the German decision to create a recreational market will completely overwhelm what appears to be a more measured, and limited progression of the issue in Switzerland.

One thing is for sure. Reform has come to the EU and the DACH region of the world. And may, beyond anything else, also finally flip Austria into the rec column too. Not to mention other countries now on the edge of recreational reform like Portugal.

It is going to be a fascinating 24 months in Europe for sure!

German Health Minister Given Cannabis Legalization Deadline By Budget Committee

In a unique twist in the annals of cannabis legalization lore, the new head of the German Health Ministry was given an ultimatum by the Bundestag’s budget committee to submit a passable recreational cannabis bill by the end of the summer

The German Health Minister Karl Lauterbach has been given a unique incentive to submit legislation that can be passed by the Bundestag by the end of the year to legalize a recreational cannabis market. Do it or have your PR budget withheld.

For his part, Lauterbach almost simultaneously issued statements to the press that he was going to speed up the process.

This means that Germany will have, all things being equal, a fully recreational cannabis market by the end of this year – legislatively at least. How long a gap between the bill’s passage and implementation is anyone’s guess. However, given the track record of legalizing jurisdictions so far, it is not inconceivable that while decriminalization and allowances for record expungement may take place more or less immediately, the actual market start may be delayed for 12-24 months. See Colorado and Canada, if not Holland.

What Could Be in The Cards

There are many question marks now on the table about what could happen next. One thing is for certain. While the Bundestag might, for convenience purposes, leave the cultivation and distribution question alone, this will in turn lead to further legal action. Nobody is happy about the cultivation bid, much less the monopoly distribution bid issued by BfArM. Keeping that as the status quo for the first source of recreational cannabis in Germany is unlikely. Even with the giveaway of open season on dispensaries (although how these should be awarded is another variable here).

Regardless, here are some of the issues that have been bandied about. Home cultivation is apparently on the table, in a win for many activists, but whether that differs for patients and recreational users is another discussion. So is the necessity for patients to have a grow license of their own.

Expect to see a heavy presence of law enforcement and heavy penalties for driving under the influence. Also expect to see at least a discussion of online shops and delivery services, even if only allowed by individual dispensaries.

It is going to be a very interesting 8 months as Germany takes its place as the second large, western economy to now proceed down the path of full and final recreational cannabis reform.

Ontario Cannabis Store Data Breach Demonstrates Growing Threat

I have worked in the cannabis industry to some degree for many years now. If you count the unregulated industry here in Oregon, I am the third generation of my family to be involved with cannabis.

If there is one thing that I know about the emerging cannabis industry it’s that cannabis and chaos seem to go hand-in-hand. Laws. Rules. Regulations. Juggling all of it while all of the parts are moving and shifting, all the while trying to be innovative and effective at running a business. There is a lot that cannabis entrepreneurs and their employees have to stay on top of and it can be like trying to drink water from a fire hydrant.

One area of the emerging cannabis industry that seems to often get lost in all of the chaos is information security, which is unfortunate. When people think of information security, they often think of computers and networks, and rightfully so. Computer networks often house a significant amount of sensitive information.

However, there is far more to information security than computers and networks. Companies and employees in the cannabis industry often house more sensitive information than people realize in both digital and physical forms, including personally identifiable information and proprietary information. All of that information is a target for someone.

Whereas network security can be easily outsourced to a reputable third party, the biggest threat to a cannabis company’s information security strategy has to be addressed on an ongoing basis in-house because that threat is the company’s own staff, either due to nefarious intent or negligence.

A cannabis company can have the most robust technical safeguards in place, with a small army of network security experts doing everything they can to keep something secure, and it only takes one person with privileged access to give up some or even all of the company’s sensitive information via less-than-sophisticated methods.

The latest example of the growing information security issue facing the emerging cannabis industry can be found in Canada where a suspected data breach is making headlines. Per Infotel:

The Ontario Cannabis Store says a data breach involving some of its sales information is being investigated by the Ontario Provincial Police.

Daffyd Roderick, a spokesperson for the Crown agency responsible for distributing cannabis from producers to pot shops in the province, confirmed what he called a misappropriation of data Tuesday evening.

“There was no failure of IT security or systems,” he added.

An OCS letter obtained by The Canadian Press and sent to retailers on May 10 said that “confidential store sales data” was being “circulated in the industry.”

“This data was not disclosed by the OCS, nor have we provided any permission or consent to distribute or use this data outside of our organization,” reads the letter signed by Janet Ihm, the OCS vice-president of wholesale partnerships and customer care.

“The data was misappropriated, disclosed, and distributed unlawfully. As a result, we trust you will refrain from sharing or using this stolen data in any way.”

As noted by authorities in the excerpt, the data breach did not come as a result of a failure of ‘IT security or systems,’ meaning, it wasn’t a direct hack into the system. Many details are still unknown, however, I would personally bet a decent chunk of change that the breach was due to non-sophisticated methods.

One of the most common ways that data breaches occur is through human error. Sometimes someone from the data source sends an email to an auto-populated wrong email address in error. Sometimes they click the wrong attachment when sending an email and the data is acquired that way, or they click ‘reply all’ when they shouldn’t have. Although, that doesn’t seem to be the case in Ontario where the ‘data was not disclosed by the OCS.’ I take that to include no direct disclosures even due to human error.

Perhaps the data was gained through some type of physical theft. When I read the word ‘misappropriated’ that is where my mind went based on the currently available information. All it would take is someone copying one or more files to a digital storage medium (disc, thumb drive, phone, etc.) containing the data in question, and simply walking off with it. Everyone has a phone in their pocket these days, and taking a picture of sensitive information is very easy to do.

Regardless of how the data was obtained in this latest case, the case itself serves as a reminder that the cannabis industry is a popular target. The industry has so much money flowing through it, it’s so competitive, and many in the industry seem to be unaware of the amount of sensitive information that they have at their fingertips. The problem will only continue to get worse.

Everyone in the cannabis industry needs to be mindful of information security threats, trends, and tactics. Companies need to train their staff, continue to educate members of their organization and create effective information security policies. One silver lining in all of this is that it creates many opportunities for ancillary companies that can help cannabis companies and organizations with their information security strategies.